|
Atomistry » Chlorine » PDB 8h8q-8huv » 8huk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 8h8q-8huv » 8huk » |
Chlorine in PDB 8huk: X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By SoakingEnzymatic activity of X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Soaking
All present enzymatic activity of X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Soaking:
2.3.1.48; Protein crystallography data
The structure of X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Soaking, PDB code: 8huk
was solved by
S.Kamata,
R.Ishikawa,
M.Akahane,
A.Honda,
T.Oyama,
I.Ishii,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Soaking
(pdb code 8huk). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Soaking, PDB code: 8huk: Chlorine binding site 1 out of 1 in 8hukGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the X-Ray Structure of Human Ppar Alpha Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Soaking
![]() Mono view ![]() Stereo pair view
Reference:
S.Kamata,
A.Honda,
R.Ishikawa,
M.Akahane,
A.Fujita,
C.Kaneko,
S.Miyawaki,
Y.Habu,
Y.Shiiyama,
K.Uchii,
Y.Machida,
T.Oyama,
I.Ishii.
Functional and Structural Insights Into the Human Ppar Alpha / Delta / Gamma Targeting Preferences of Anti-Nash Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor Antioxidants V. 12 1523 2023.
Page generated: Sun Jul 13 12:07:25 2025
ISSN: ESSN 2076-3921 DOI: 10.3390/ANTIOX12081523 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |